Macquarie Group’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-212,676
| Closed | -$4.68M | – | 1698 |
|
|
2025
Q1 | $4.68M | Buy |
212,676
+20,000
| +10% | +$470K | 0.01% | 998 |
|
|
2024
Q4 | $4.37M | Buy |
192,676
+72,454
| +60% | +$1.58M | 0.01% | 977 |
|
|
2024
Q3 | $2.18M | Sell |
120,222
-91,533
| -43% | -$2.12M | ﹤0.01% | 1200 |
|
|
2024
Q2 | $6.17M | Sell |
211,755
-511,333
| -71% | -$15.2M | 0.01% | 927 |
|
|
2024
Q1 | $25.6M | Sell |
723,088
-166,341
| -19% | -$6.65M | 0.03% | 616 |
|
|
2023
Q4 | $38.7M | Sell |
889,429
-575,696
| -39% | -$22.7M | 0.04% | 513 |
|
|
2023
Q3 | $56M | Sell |
1,465,125
-191,181
| -12% | -$8.04M | 0.07% | 372 |
|
|
2023
Q2 | $68.1M | Sell |
1,656,306
-55,913
| -3% | -$2.69M | 0.08% | 337 |
|
|
2023
Q1 | $98.3M | Buy |
1,712,219
+5,256
| +0.3% | +$296K | 0.12% | 236 |
|
|
2022
Q4 | $95.7M | Sell |
1,706,963
-53,033
| -3% | -$2.7M | 0.11% | 251 |
|
|
2022
Q3 | $74.6M | Buy |
1,759,996
+366,545
| +26% | +$18.8M | 0.09% | 299 |
|
|
2022
Q2 | $75.3M | Buy |
1,393,451
+9,430
| +0.7% | +$566K | 0.08% | 321 |
|
|
2022
Q1 | $88.9K | Buy |
1,384,021
+2,264
| +0.2% | +$149K | 0.07% | 331 |
|
|
2021
Q4 | $92.6M | Sell |
1,381,757
-25,518
| -2% | -$1.73M | 0.08% | 323 |
|
|
2021
Q3 | $96.4M | Buy |
1,407,275
+5,382
| +0.4% | +$380K | 0.08% | 310 |
|
|
2021
Q2 | $95.7M | Buy |
1,401,893
+160,517
| +13% | +$11.4M | 0.08% | 319 |
|
|
2021
Q1 | $85.8M | Sell |
1,241,376
-31,980
| -3% | -$2.17M | 0.12% | 193 |
|
|
2020
Q4 | $82.7M | Buy |
1,273,356
+156,838
| +14% | +$8.44M | 0.12% | 188 |
|
|
2020
Q3 | $52.7M | Buy |
1,116,518
+477,890
| +75% | +$22.7M | 0.09% | 247 |
|
|
2020
Q2 | $30M | Buy |
638,628
+585,936
| +1,112% | +$28.8M | 0.05% | 374 |
|
|
2020
Q1 | $2.35M | Buy |
52,692
+1,847
| +4% | +$96.9K | ﹤0.01% | 876 |
|
|
2019
Q4 | $2.96M | Buy |
50,845
+6,075
| +14% | +$362K | ﹤0.01% | 933 |
|
|
2019
Q3 | $2.69M | Buy |
+44,770
| New | +$2.67M | ﹤0.01% | 944 |
|
|
2018
Q2 | – | Sell |
-40,805
| Closed | -$2.26M | – | 2224 |
|
|
2018
Q1 | $2.26M | Buy |
+40,805
| New | +$2.14M | ﹤0.01% | 957 |
|
|
2017
Q3 | – | Sell |
-51,300
| Closed | -$2.8M | – | 2139 |
|
|
2017
Q2 | $2.8M | Hold |
51,300
| – | – | 0.01% | 884 |
|
|
2017
Q1 | $2.16M | Buy |
+51,300
| New | +$2.19M | ﹤0.01% | 946 |
|
|
2016
Q4 | – | Sell |
-58,800
| Closed | -$2.43M | – | 1556 |
|
|
2016
Q3 | $2.43M | Sell |
58,800
-58,800
| -50% | -$2.46M | ﹤0.01% | 903 |
|
|
2016
Q2 | $4.69M | Buy |
117,600
+47,200
| +67% | +$1.7M | ﹤0.01% | 889 |
|
|
2016
Q1 | $2.37M | Hold |
70,400
| – | – | ﹤0.01% | 907 |
|
|
2015
Q4 | $2.39M | Hold |
70,400
| – | – | ﹤0.01% | 891 |
|
|
2015
Q3 | $2.1M | Sell |
70,400
-15,716
| -18% | -$491K | ﹤0.01% | 955 |
|
|
2015
Q2 | $2.37M | Hold |
86,116
| – | – | ﹤0.01% | 977 |
|
|
2015
Q1 | $2.17M | Hold |
86,116
| – | – | ﹤0.01% | 999 |
|
|
2014
Q4 | $1.91M | Hold |
86,116
| – | – | ﹤0.01% | 1031 |
|
|
2014
Q3 | $1.75M | Buy |
+86,116
| New | +$1.71M | ﹤0.01% | 1043 |
|
Other funds holding IART
RCMNY
PCMI
Macquarie Group's IART Position: Q2 2025 in Review
Macquarie Group sold out of Integra LifeSciences (IART) in Q2 2025, closing a stake of 212,676 shares — an estimated $4.68M sold.
Macquarie Group first reported a position in IART in Q3 2014 and held it in 35 quarters. The position peaked at $98.3M in Q1 2023. 208 funds tracked by Wall St. Rank hold IART as of Q2 2025.
- Macquarie Group reported no remaining Integra LifeSciences position as of Q2 2025 after selling out during the quarter.
- Macquarie Group sold 212,676 Integra LifeSciences shares in Q2 2025, an estimated $4.68M.
- Macquarie Group first reported a position in Integra LifeSciences in Q3 2014 and held it in 35 quarters.
- Macquarie Group's Integra LifeSciences position peaked at $98.3M in Q1 2023.
- 208 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2025.
Based on Macquarie Group's 13F filing for Q2 2025, filed 14 Aug 2025.